![Hugues Bienaymé](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugues Bienaymé
Chief Executive Officer at
ORPHELIA Pharma SAS
Profile
Dr. Hugues Bienaymé is a CEO, Director & Chief Scientific Officer at ORPHELIA Pharma SAS. He is on the Board of Directors at ORPHELIA Pharma SAS. Dr. Bienaymé was previously employed as a Principal by Chrysalon SA, a Managing Director by Urogene SA, and a Principal by Rhône-Poulenc, Inc.
Hugues Bienaymé active positions
| Companies | Position | Start |
|---|---|---|
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Chief Executive Officer | 2006-12-31 |
Former positions of Hugues Bienaymé
| Companies | Position | End |
|---|---|---|
Urogene SA
 Urogene SA Miscellaneous Commercial ServicesCommercial Services Specializes in preclinical and clinical development of drugs | Founder | 2012-10-16 |
Rhône-Poulenc, Inc. | Corporate Officer/Principal | - |
Chrysalon SA
 Chrysalon SA Miscellaneous Commercial ServicesCommercial Services Researches and develops medicinal chemical products and pharmaceuticals | Corporate Officer/Principal | 2002-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Urogene SA
Urogene SA Miscellaneous Commercial ServicesCommercial Services Specializes in preclinical and clinical development of drugs | Commercial Services |
Chrysalon SA
Chrysalon SA Miscellaneous Commercial ServicesCommercial Services Researches and develops medicinal chemical products and pharmaceuticals | Commercial Services |
Rhône-Poulenc, Inc. | Process Industries |
ORPHELIA Pharma SAS
ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology Specializes on biopharmaceutical products improving the health and well being of severely disabled children | Health Technology |
- Stock Market
- Insiders
- Hugues Bienaymé
